Evidence map›Paper›PMID 21681456›Full record

ReviewDer Urologe. Ausg. A2011

[Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].

M Goepel, D Schultz-Lampel

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

M GoepelKlinik für Urologie und Kinderurologie, Klinikum Niederberg, Robert-Koch-Straße 2, 42549 Velbert, Deutschland. goepel@klinikum-niederberg.de
D Schultz-Lampel
Klinikum Vest · DENephrologisches Zentrum Villingen-Schwenningen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overactive-bladder syndrome is characterized by the symptoms pollakisuria, nocturia and urgency with and without urge incontinence. The primary diagnostic procedure includes noninvasive or minimally invasive techniques. Antimuscarinic drugs lead within the therapeutic cascade. Only after unsuccessful use of several antimuscarinics should further treatment options such as electromotive drug administration or infiltration of the detrusor muscle with botulinum toxin A be discussed. The presented review article tries to give an overview by including the existing head-to-head-studies in this field.

Indexed as

AgedBotulinum Toxins, Type ACholinergic AntagonistsCombined Modality TherapyFemaleHumansMiddle AgedMuscarinic AntagonistsNocturiaRandomized Controlled Trials as TopicUrinary Bladder, OveractiveUrinary Incontinence, UrgeUrodynamicsBotulinum Toxins, Type ACholinergic AntagonistsMuscarinic Antagonists

Identifiers

PMID21681456
OpenAlexW1523632869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.